The 88.4% medical care ratio demonstrates solid performance while managing through pandemic-related medical cost challenges that increased the ratio by 110 basis points.
Last night, we reported adjusted earnings per diluted share for the second quarter of $3.40, with adjusted net income of $199 million and premium revenue of $6.6 billion.
And we accomplished all of this as we generated approximately 50% year-over-year premium revenue growth and successfully integrated businesses, representing approximately $5 billion in annual revenue.